Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05992194
Other study ID # SBN_2023_2
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 23, 2023
Est. completion date November 2, 2023

Study information

Verified date February 2024
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Traumatic brain injury (TBI) is a condition that occurs when a mechanical blow to the head causes damage to the brain. The diagnosis of this pathology requires the evaluation of several dimensions, including clinical symptoms, physical signs, cognitive disorders, behavioral and sleep disturbances and state of consciousness. This multidimensional approach provides a comprehensive and accurate assessment of head injury and its severity. The Berlin Consensus of the International Conference on Concussion in Contact Risk Sports held in Berlin in 2016 (McCrory et al., 2017) emphasized that the management of a CTE must be multimodal and multidisciplinary. This expert consensus converged on a tool that is now the most widely used in protocols studying concussion in sports at risk of BTI. This tool, the SCAT 5 (Sports Concussion Assessment Tool), combines symptom assessment, cognitive examination, neurological examination (oculomotricity, balance) and immediate and delayed memory. However, it requires the intervention of a medical expert to assess the clinical signs of the concussed athlete. Hänninen et al (2021) showed that test-retest reproducibility was very good for the clinical symptomatology subscore, but poor or average for the subscores summarizing cognitive tests and balance assessment. Clinicians now need to be able to better assess the severity of damage following head injury, and to monitor the patient's progress. This will improve the management of concussed athletes right up to their eventual return to sporting activity. The ultimate aim of our project is to develop and optimize an easily exportable multimodal concussion assessment tool, based on the use of a virtual reality headset, which will enable us to objectively characterize the state and evolution of a subject after a TCE. This will enable the assessment of neuro-visual functions and compensations in the concussed patient, revealing a higher attentional cost characterized by instability of orthostatic control, higher blink frequency and larger pupil size. The multimodal tool will be built from the results of various tests: - Standardized oculomotor tasks(pro-saccades, anti-saccades, smooth pursuit, memory guided saccades, self paced saccades) - Orthostatic balance control to assess postural compensations and estimate attentional cost during oculomotor tasks. - Pupil dynamics using the Pupil Cycle Time (PCT) test. The aim of this exploratory study is to determine the repeatability of measurements provided by the SPORTiCARE virtual reality headset during different tasks.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date November 2, 2023
Est. primary completion date November 2, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Visual acuity of 10/10, - Express consent to participate in the study, - Affiliated (or beneficiary) of a social insurance scheme. Exclusion Criteria: - History of Cranioencephalic Trauma, - Protected persons: pregnant women, parturients, nursing mothers, persons deprived of their liberty by judicial or administrative decision, minors, and persons subject to a legal protection measure (guardianship or curatorship). - Subjects suffering from a degenerative disease or any other illness which could interfere with the evaluations planned during this study (migraine, balance disorders, vertigo). - Subjects with ophthalmological pathologies affecting visual functions (oculomotor dysfunction, diplopia, strabismus). - Known history of convergence and/or accommodation insufficiency. - Subject declaring to the investigator in charge of anamnesis, consumption of psychoactive and psychotropic drugs, medications (anti-anxiety, antidepressant, anticonvulsant, opiate, analgesic, anti-hypertensive) or level 3 medications, which may have effects on vision. - Unavailability of participant for evaluation sessions. - Inability to comply with study task instructions.

Study Design


Intervention

Other:
multimodal oculomotor measurements
Visual assessment to ensure that the subject meets the inclusion and non-inclusion criteria, including anamnesis and the following visual tests: Lang stereotest, H-test ocular motility, convergence, masking and accommodative rock. Evaluation by experimenter A (60 min) Neuro-ophthalmological tests on screen Neuro-ophthalmological tests in VR headset Evaluation by experimenter B (60 min) Neuro-ophthalmological tests on screen Neuro-ophthalmological tests in VR helmet The sequence of experimenters A-B or B-A will be randomized.

Locations

Country Name City State
France Streetlab - Institut de la Vision Paris

Sponsors (1)

Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of repeatability when performing pro-saccades Latency (ms) Day 0
Primary Assessment of repeatability when performing anti-saccades Latency (ms) Day 0
Primary Assessment of repeatability when performing memory tricks Positional error (degrees) Day 0
Primary Assessment of repeatability of the number of saccades when performing self-paced saccades number of saccades (n) performed between the two targets in the allotted time (15 seconds) Day 0
Primary Assessment of repeatability of pupil cycle time when performing self-paced saccades Pupil Cycle Time (PCT): average frequency of pupillary oscillation (Hz) Day 0
Primary Assessment of repeatability when performing pro-saccades Latency (ms) Between Day 7 and Day 21
Primary Assessment of repeatability when performing anti-saccades Latency (ms) Between Day 7 and Day 21
Primary Assessment of repeatability when performing memory tricks Positional error (degrees) Between Day 7 and Day 21
Primary Assessment of repeatability of the number of saccades when performing self-paced saccades number of saccades (n) performed between the two targets in the allotted time (15 seconds) Between Day 7 and Day 21
Primary Assessment of repeatability of pupil cycle time when performing self-paced saccades Pupil Cycle Time (PCT): average frequency of pupillary oscillation (Hz) Between Day 7 and Day 21
See also
  Status Clinical Trial Phase
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Terminated NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT05130658 - Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training N/A
Recruiting NCT04560946 - Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI N/A
Completed NCT05160194 - Gaining Real-Life Skills Over the Web N/A
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03940443 - Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Recruiting NCT03899532 - Remote Ischemic Conditioning in Traumatic Brain Injury N/A
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Completed NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Withdrawn NCT04199130 - Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI N/A
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1